Retatrutide — lab test, April 2026
ILS Laboratories publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 14 mg · Lab measured 14.64 mg
105% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 3.7 mg using the measured mass, against 3.5 mg on the label — 5% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Triple Agonist, performed by ILS Laboratories on April 4, 2026. Reported purity: 99.61%. Net content: 14.64 mg against 14 mg labeled (105% of label). Endotoxins: NMT 0.05 EU/mL. Batch CR-3XAG14-2604-1. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion